Roots Analysis

APRIL 5, 2023

In fact, non-viral vectors are significantly less expensive than their virus-based counterparts, implying the potential for use in the development of more affordable gene therapies. Currently, highest number of patent for non-viral transfection reagents and systems is filed in North America region.

Reagent 52

Reagent Marketing Gene Therapy Gene 52

XTalks

JUNE 27, 2022

Leading global medical technology company Becton Dickinson (BD) and Spain’s CerTest Biotec have announced they will be collaborating to develop a molecular diagnostic test for the detection of the monkeypox virus. However, he said the global health agency is closely monitoring the evolving situation.

Development 83

Development In-Vitro Reagent Vaccination 83

Drug Discovery World

MARCH 27, 2023

Cell therapy research has never been more exciting with all of the research ongoing. Download this new white paper ‘Diving deep into cell therapy: An industry perspective’ to find out more. The post New whitepaper: Take a deep dive into cell therapy appeared first on Drug Discovery World (DDW).

Reagent 52

Reagent Manufacturing Development Research 52

Roots Analysis

JUNE 1, 2022

The pandemic has specifically resulted in enhanced research and development activities in the field of biotechnology. Recent technological advancements have led to development of novel DNA cloning kits and reagents, which are cost-effective, faster and more efficient than conventional methods. DNA Cloning Reagents Market.

DNA 52

DNA Genetics Reagent Marketing 52

STAT News

AUGUST 26, 2022

This time around, we note that  Ansa Biotechnologies hired Jeremiah Hanes as senior vice president, research and development. Previously, he worked at PacBio, where he was most recently vice president, reagents R&D. And here is our regular feature in which we highlight a different person each week.

Reagent 98

Reagent Development Research 98

Drug Discovery World

MARCH 27, 2023

Cell therapy research has never been more exciting with all of the research ongoing.

Reagent 52

Reagent Manufacturing Development Drugs 52

FDA Law Blog

JANUARY 4, 2023

Brevig, Senior Regulatory Device and Biologics Expert — On December 7, 2022, FDA’s Center for Biologics Evaluation and Research (CBER) and the Office of Tissues and Advanced Therapies (OTAT) held a town hall to answer questions related to cell therapy and tissue-engineered products chemistry, manufacturing, and contr­­ols (CMC).

Reagent 59

Reagent Manufacturing Production Gene Therapy 59

Drug Discovery World

MAY 25, 2023

The platform works with the SYNTAX Hi-Fidelity reagent kits for synthesising longer oligos. The modular, cloud native Torx platform enables chemistry teams to collaborate and share molecules, both internally and with contract research organisations (CROs) around the world.

Production 52

Production Reagent DNA Drugs 52

Scienmag

OCTOBER 15, 2020

Credit: LIU Hongji A joint research team led by Prof. WANG Hui and Prof.

Reagent 85

Reagent Scientist Development Research 85

Drug Discovery World

FEBRUARY 6, 2023

Users can add the dedicated CAS SciFinder plugin window to their Torx design environment to search and display the results in CAS SciFinder, alongside real-time critical physico-chemical, near-neighbor, and 3D-pose information about their small molecules in Torx.

Reagent 52

Reagent Drugs Medicine Research 52

Drug Discovery World

AUGUST 11, 2023

The news headlines this week reflect the level of interest in cell & gene therapies (CGT) in the sector, particularly CAR-T, but also the importance of research collaborations to bring these therapies to patients. News round-up for by DDW Digital Content Editor Diana Spencer.

Gene Therapy 52

Gene Therapy Drugs Clinical Trials Clinical Trials 52

BioTech 365

AUGUST 16, 2021

SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline Additional research reagents to detect mutations associated with delta variant of concern now available SYDNEY–(BUSINESS WIRE)–#COVID19–SpeeDx Pty.

Reagent 52

Reagent Development Research 52

Drug Discovery World

NOVEMBER 2, 2023

You will hear from Fiona Elwood, VP, Disease Area Stronghold Lead, Neurodegeneration, Janssen, and Jenny Barnett, CEO of Monument TX, as well as Rosanna Zhang, Vice President of Corporate Development at ACROBiosystems. She will share examples of this precision medicine approach in cognitive impairment in schizophrenia and neuroinflammation.

Reagent 52

Reagent Drugs Development Medicine 52

pharmaphorum

NOVEMBER 26, 2020

London-based Salient was founded by former team members of Imperial College’s London BioFoundry, which handled the spin-out and accelerates commercialisation of synthetic biology research and technology.

Reagent 93

Reagent Vaccination Vaccine Development 93

Drug Discovery World

OCTOBER 26, 2023

You will hear from Fiona Elwood, VP, Disease Area Stronghold Lead, Neurodegeneration, Janssen, and Jenny Barnett, CEO of Monument TX, as well as Rosanna Zhang, Vice President of Corporate Development at ACROBiosystems. She will share examples of this precision medicine approach in cognitive impairment in schizophrenia and neuroinflammation.

Reagent 52

Reagent Drugs Development Medicine 52

Drug Discovery World

OCTOBER 19, 2023

You will hear from Fiona Elwood, VP, Disease Area Stronghold Lead, Neurodegeneration, Janssen, and Jenny Barnett, CEO of Monument TX, as well as Rosanna Zhang, Vice President of Corporate Development at ACROBiosystems. She will share examples of this precision medicine approach in cognitive impairment in schizophrenia and neuroinflammation.

Reagent 52

Reagent Drugs Development Medicine 52

Drug Discovery World

OCTOBER 12, 2023

You will hear from Fiona Elwood, VP, Disease Area Stronghold Lead, Neurodegeneration, Janssen, and Jenny Barnett, CEO of Monument TX, as well as Rosanna Zhang, Vice President of Corporate Development at ACROBiosystems. She will share examples of this precision medicine approach in cognitive impairment in schizophrenia and neuroinflammation.

Reagent 52

Reagent Drugs Development Medicine 52

BioTech 365

SEPTEMBER 7, 2020

Avacta to make a high performance Affimer research ELISA test available to support global research efforts to combat the coronavirus CAMBRIDGE & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce … Continue reading →

Reagent 52

Reagent Research Development 52

The Pharma Data

MAY 17, 2021

Academic centers should establish risk management programs to successfully commercialize cell and gene therapy products and to be a viable partner with contract research organizations (CROs) and manufacturers in developing these therapies. . Uharek is a hematologist and cell and gene therapy specialist at Berlin’s Charité Hospital.

Development 52

Development Gene Therapy Manufacturing Gene 52

BioTech 365

FEBRUARY 23, 2021

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents DUBLIN & SEOUL–(BUSINESS WIRE)–ERS Genomics Limited, which … Continue reading →

Life Science 52

Life Science Genome Genomics Licensing 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

Victoza, Copaxone, Lupron, Zoladex, Sandostatin, and Somatuline are some of the popularly marketed peptide API therapeutic drugs while more than 600 peptide-based pharmacological leads are being investigated worldwide, across various phases of development. Technologies in the delivery of peptides and proteins.

Protein 130

Protein Marketing Manufacturing Reagent 130

Drug Discovery World

MAY 10, 2023

Based on two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity will provide reagents, consumables, assays, instruments and software to customers from pharma and biotech, diagnostic labs, academia and government agencies. Revvity has now officially launched as a science-based solutions company.

Life Science 52

Life Science Reagent Genome Genomics 52

Drug Discovery World

MAY 10, 2023

Based on two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity will provide reagents, consumables, assays, instruments and software to customers from pharma and biotech, diagnostic labs, academia and government agencies. Revvity has now officially launched as a science-based solutions company.

Life Science 52

Life Science Reagent Genome Genomics 52

Camargo

JUNE 9, 2021

Camargo Research Group , Camargo’s managed nonclinical solution, has worked on more than 200 nonclinical programs since its inception in 2005, many of which include rare routes of administrations (ROAs) and use of uncommon animal species. Niche Nonclinical Routes of Administrations. Guinea pig.

Reagent 178

Reagent Production Drugs Allergies 178

XTalks

AUGUST 18, 2020

The test has been developed by researchers at the Yale School of Public Health and is being touted as a game changer for fast and easy COVID testing. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing. Non-Proprietary Technology.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

Drug Discovery World

JANUARY 30, 2024

Lentivirus strategies are one of the most widely used tools in biomedical research and clinical testing, says Stella Vnook, CEO, Likarda. “Dr High-cost materials: Specialised equipment, reagents, and cell culture media significantly contribute to the overall cost. Developing more efficient and affordable alternatives is key.

Gene Therapy 71

Gene Therapy Manufacturing Gene Clinical Trials 71

pharmaphorum

DECEMBER 16, 2022

Dopavision, a DTx company in the eye health space, has brought on ophthalmology and neuroscience expert Dirk Sauer , a veteran of Novartis Pharma, to advise the company as it continues to develop MyopiaX, a digital therapeutic for childhood myopia control. AI and robotics hires. McKinnell, Jr. to support the company’s growth.

Behavioural Health 52

Behavioural Health Reagent Gene Therapy Production 52

Camargo

MAY 2, 2021

Advances in scientific knowledge and growth in the cell and gene therapy space have led to a new and exciting era of medicine for patients, as well as a new motivation for regulators to provide clear, efficient pathways for product developers. Source: Medicines in Development | 2020 Update: Cell and Gene Therapy , PhRMA.

Gene Therapy 155

Gene Therapy Gene Packaging Packaging 155

Drug Discovery World

MAY 7, 2024

Ultimately, we owe it to patients to work together and come up with new and innovative manufacturing as well as process development approaches to accelerate the development and achieve speed to clinic. RA: In recent years, what improvements have we seen to cell-line engineering for antibodies?

Antibody 59

Antibody Production Manufacturing Engineer 59

Drug Discovery World

JANUARY 10, 2023

Our catalog of over 6,500+ primary antibodies, 1,200+ secondary antibodies, and 50+ ELISA kits includes reagents for multiplex IF, flow cytometry, and more in fields including immunology, oncology, and neuroscience. Custom antibody development. For many of our clients, we realise that cutting-edge research requires custom solutions.

Antibody 52

Antibody Protein Reagent Scientist 52

pharmaphorum

AUGUST 16, 2020

There are profound changes taking place in the area of life science research and development,” stated Swittons CEO and Founder Anupam Nandwana. Reorder reagents. Swittons is powered by the technology and expertise developed by P360. Notify of spill/cleaning needed. Equipment occupancy notification. Summon a lab runner.

Life Science 129

Life Science Reagent Scientist Clinical Trials 129

Roots Analysis

FEBRUARY 21, 2022

Advancement in DNA sequencing technologies have resulted in noteworthy developments in various healthcare-related research fields, such as diagnostics and personalized medicine. Moreover, the manual protocols require extensive manipulation, costly reagents and long duration of skilled genomic library production.

Marketing 52

Marketing Gene Sequencing DNA Genome 52

The Pharma Data

JANUARY 24, 2021

Headquartered in Paris, France, AIT supplies public and private researchers and pharmaceutical laboratories. Ben Travis, CEO of Calibre Scientific, had this to say about the acquisition: “AIT has developed deep and valuable partnerships across Europe due, in large part, to their expertise and customer service. About Calibre Scientific.

Life Science 52

Life Science Reagent Manufacturing Production 52

Drug Discovery World

FEBRUARY 9, 2023

Cytek Biosciences and Bio-Rad Laboratories have entered into a strategic development partnership. Under the terms of the agreement, Bio-Rad’s new StarBright Dyes will be available to Cytek to develop and commercialise reagent products to support high-parameter applications on Aurora and Northern Lights flow cytometry systems.

Reagent 52

Reagent Development Production Marketing 52

pharmaphorum

JANUARY 25, 2022

Canadian firm BenchSci has secured around $50 million in third-round financing that will be used to speed up the adoption of its artificial intelligence-powered platform for biomedical research internationally. The company is tapping into longstanding concerns in the life science industry about R&D productivity.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52

Advarra

NOVEMBER 29, 2022

The field of cell and gene therapies (CGT) is constantly evolving, and there has been significant progress in this area of research. There have been recent signals indicating the Food and Drug Administration (FDA) plans to provide greater support for CGT, addressing key issues continuing to impede their development.

Gene Therapy 52

Gene Therapy Gene Production Clinical Trials 52

The Pharma Data

SEPTEMBER 8, 2021

TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic. The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche`s LightCycler PCR instruments. About TIB Molbiol.

Genotype 52

Genotype Reagent Genetics Research 52